David Rometo, MD, reflects on the sustainability of incremental weight loss programs and aggressive diets. A weight loss ...

Telemedicine significantly improved quality of life and inhaler technique in advanced COPD patients compared to traditional ...

Bouchard opened a discussion on sequencing therapies in MM, noting that CAR T-cell therapy and bispecific antibodies each ...

Collaboration between community practices and academic institutions is crucial for administering bispecific antibodies, with ...

AI-driven prior authorizations (PAs) are trusted by many clinicians, promising to streamline processes and reduce ...

An expert discusses how rilzabrutinib’s covalent reversible binding mechanism provides a favorable safety profile with only manageable grade 1 to 2 toxicities and no cardiovascular or bleeding ...

Recent advancements in medical therapy for heart failure with mildly reduced ejection fraction (HFmrEF) or preserved ejection ...

Surgeons who previously shared patients with physicians who frequently performed opportunistic salpingectomy (OS) were more likely to adopt the procedure themselves, according to a study published in ...

An expert discusses how the phase 3 LUNA 3 trial demonstrated that rilzabrutinib achieved durable platelet responses in 23% of patients while also being the first prospective trial to show significant ...

UC Davis Health enhances patient care through a shared services center, ensuring continuity of care and optimizing pharmacy growth strategies.

Lindsey Valenzuela, PharmD, explains how atypical symptoms, research gaps, and care inequities delay arrhythmia detection in women. Women with arrhythmia are too often overlooked—not because their ...

Efgartigimod demonstrated superior efficacy over IVIG in improving MG-ADL and QMG scores in myasthenia gravis patients. Patients treated with efgartigimod experienced faster symptom improvement and ...